{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:28:29Z","timestamp":1777688909129,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Recent studies reported that in polycystic ovary syndrome (PCOS) patients, other stimulation agents are superior to the popular first-line regimen, clomiphene citrate (CC) for ovarian stimulation. Nonetheless, CC is still widely used since it is not clear which patients will not respond to it. Furthermore, the prognostic value of endometrium thickness at midcycle is controversial. We aimed to find factors predicting the response to CC and the prognostic value of endometrial thickness at midcycle.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We collected data retrospectively from 89 anovulatory PCOS patients who had the first stimulation with 50\u00a0mg CC. We analyzed the basal levels of AMH, testosterone, LH, LH:FSH ratio and the endometrial thickness at midcycle by univariate, followed by multivariate regression. The outcome measures were pregnancy, follicle maturation and endometrial thickness at midcycle.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Stimulation with 50\u00a0mg CC resulted in follicle maturation in 50.6% of the women and in 27.0% pregnancies. In the univariate analysis, greater endometrial thickness, lower LH and AMH levels and a lower LH:FSH ratio were associated with pregnancy (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). In the multivariate analysis, only endometrial thickness remained predictive (<jats:italic>p<\/jats:italic>\u2009=\u20090.045). The endometrial thickness cutoff level of\u2009\u2265\u20098\u00a0mm showed a sensitivity of 87.5% (96% CI 67.6\u201397.3) and a specificity of 66.7% (95% CI 43.0\u201385.4) for prediction of pregnancy. In the multivariate analysis AMH levels 5.4 (3.4; 7.0) (ng\/mL) predicted pregnancy (<jats:italic>\u03b2<\/jats:italic>\u2009=\u2009\u2212 0.194\u2009\u00b1\u20090.092; <jats:italic>p<\/jats:italic>\u2009=\u20090.034)<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We suggest to refrain from CC as first-line regimen in patients with AMH\u2009&gt;\u20097\u00a0ng\/ml. Under CC treatment, the cutoff value of\u2009\u2265\u20098\u00a0mm endometrium thickness at midcycle is associated with a better outcome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00404-019-05359-7","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T12:03:12Z","timestamp":1573041792000},"page":"1751-1757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Basal Anti Mullerian hormone levels and endometrial thickness at midcycle can predict the outcome after clomiphene citrate stimulation in anovulatory women with PCOS, a retrospective study"],"prefix":"10.1007","volume":"300","author":[{"given":"Aulona","family":"Gaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"H\u00f6rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Hager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrig","family":"Marculescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-5262","authenticated-orcid":false,"given":"Johannes","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"issue":"6","key":"5359_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R et al (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metabol 89(6):2745\u20132749","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"5359_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","volume":"375","author":"CR McCartney","year":"2016","unstructured":"McCartney CR, Marshall JC (2016) Clinical practice. Polycystic ovary syndrome. New Engl J Med 375(1):54\u201364","journal-title":"New Engl J Med"},{"issue":"4","key":"5359_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1530\/EJE-14-0252","volume":"171","author":"G Conway","year":"2014","unstructured":"Conway G et al (2014) European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire. Eur J Endocrinol 171(4):489\u2013498","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"5359_CR4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00404-018-4688-6","volume":"297","author":"S Hu","year":"2018","unstructured":"Hu S et al (2018) Letrozole versus clomiphene citrate in polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Arch Gynecol Obstet 297(5):1081\u20131088","journal-title":"Arch Gynecol Obstet"},{"key":"5359_CR5","first-page":"p.CD010287","volume":"5","author":"S Franik","year":"2018","unstructured":"Franik S et al (2018) Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev 5:p.CD010287","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"5359_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ et al (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 110(3):364\u2013379","journal-title":"Fertil Steril"},{"issue":"6","key":"5359_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/oxfordjournals.humrep.a137165","volume":"5","author":"Y Gonen","year":"1990","unstructured":"Gonen Y, Casper RF (1990) Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 5(6):670\u2013674","journal-title":"Hum Reprod"},{"issue":"2","key":"5359_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0015-0282(97)81907-3","volume":"67","author":"Y Nakamura","year":"1997","unstructured":"Nakamura Y et al (1997) Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril 67(2):256\u2013260","journal-title":"Fertil Steril"},{"issue":"3","key":"5359_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/biolre\/ioy187","volume":"100","author":"S Mehdinejadiani","year":"2018","unstructured":"Mehdinejadiani S et al (2018) Effects of letrozole and clomiphene citrate on Wnt signaling pathway in endometrium of polycystic ovarian syndrome and healthy women. Biol Reprod 100(3):641\u2013648","journal-title":"Biol Reprod"},{"issue":"1","key":"5359_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/uog.18933","volume":"51","author":"MA Gadalla","year":"2018","unstructured":"Gadalla MA et al (2018) Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis. Ultrasound Obstet Gynecol 51(1):64\u201376","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5359_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cca.2017.06.009","volume":"471","author":"SE Karakas","year":"2017","unstructured":"Karakas SE (2017) New biomarkers for diagnosis and management of polycystic ovary syndrome. Clin Chim Acta 471:248\u2013253","journal-title":"Clin Chim Acta"},{"issue":"4","key":"5359_CR12","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.fertnstert.2008.01.028","volume":"91","author":"J Wang","year":"2009","unstructured":"Wang J et al (2009) Evidence for a Mullerian-inhibiting substance autocrine\/paracrine system in adult human endometrium. Fertil Steril 91(4):1195\u20131203","journal-title":"Fertil Steril"},{"issue":"9","key":"5359_CR13","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1210\/jc.2012-1538","volume":"97","author":"J Namkung","year":"2012","unstructured":"Namkung J et al (2012) Mullerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosis. J Clin Endocrinol Metabol 97(9):3224\u20133230","journal-title":"J Clin Endocrinol Metabol"},{"key":"5359_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-9966-33-46","volume":"33","author":"PG Signorile","year":"2014","unstructured":"Signorile PG, Petraglia F, Baldi A (2014) Anti-mullerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cells. J Exp Clin Cancer Res 33:46","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"5359_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.fertnstert.2005.09.053","volume":"85","author":"S Quezada","year":"2006","unstructured":"Quezada S et al (2006) Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome. Fertil Steril 85(4):1017\u20131026","journal-title":"Fertil Steril"},{"issue":"1","key":"5359_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijgo.2015.09.008","volume":"133","author":"HE Ellakwa","year":"2016","unstructured":"Ellakwa HE et al (2016) Predictors of patient responses to ovulation induction with clomiphene citrate in patients with polycystic ovary syndrome experiencing infertility. Int J Gynaecol Obstet 133(1):59\u201363","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"5359_CR17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMoa063971","volume":"356","author":"RS Legro","year":"2007","unstructured":"Legro RS et al (2007) Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356(6):551\u2013566","journal-title":"N Engl J Med"},{"issue":"1","key":"5359_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.fertnstert.2013.08.056","volume":"101","author":"RS Legro","year":"2014","unstructured":"Legro RS et al (2014) The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial. Fertil Steril 101(1):258\u2013269","journal-title":"Fertil Steril"},{"issue":"2","key":"5359_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1056\/NEJMoa1313517","volume":"371","author":"RS Legro","year":"2014","unstructured":"Legro RS et al (2014) Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 371(2):119\u2013129","journal-title":"N Engl J Med"},{"issue":"11","key":"5359_CR20","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/humrep\/deg461","volume":"18","author":"P Kovacs","year":"2003","unstructured":"Kovacs P et al (2003) The effect of endometrial thickness on IVF\/ICSI outcome. Hum Reprod 18(11):2337\u20132341","journal-title":"Hum Reprod"},{"issue":"11","key":"5359_CR21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3109\/09513590.2010.540602","volume":"27","author":"P Kuc","year":"2011","unstructured":"Kuc P et al (2011) The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes. Gynecol Endocrinol 27(11):867\u2013873","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"5359_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1472-6483(10)60505-6","volume":"8","author":"EM Kolibianakis","year":"2004","unstructured":"Kolibianakis EM et al (2004) Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reprod Biomed Online 8(1):115\u2013118","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"5359_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","volume":"89","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","unstructured":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Fertil steril 89(3):505\u2013522","journal-title":"Fertil steril"},{"issue":"1","key":"5359_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reprod 19(1):41\u201347","journal-title":"Human Reprod"},{"issue":"2","key":"5359_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/MCA.0000000000000321","volume":"27","author":"M Abd Alamir","year":"2016","unstructured":"Abd Alamir M et al (2016) The Cardiovascular Trial of the Testosterone Trials: rationale, design, and baseline data of a clinical trial using computed tomographic imaging to assess the progression of coronary atherosclerosis. Coron Artery Dis 27(2):95\u2013103","journal-title":"Coron Artery Dis"},{"issue":"4","key":"5359_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0015-0282(16)60964-0","volume":"52","author":"CH Wu","year":"1989","unstructured":"Wu CH, Winkel CA (1989) The effect of therapy initiation day on clomiphene citrate therapy. Fertil Steril 52(4):564\u2013568","journal-title":"Fertil Steril"},{"issue":"2","key":"5359_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0015-0282(16)46033-4","volume":"37","author":"M Gysler","year":"1982","unstructured":"Gysler M et al (1982) A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril 37(2):161\u2013167","journal-title":"Fertil Steril"},{"issue":"12","key":"5359_CR28","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS et al (2013) Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 98(12):4565\u20134592","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"5359_CR29","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1002\/sim.2771","volume":"26","author":"E Demidenko","year":"2007","unstructured":"Demidenko E (2007) Sample size determination for logistic regression revisited. Stat Med 26(18):3385\u20133397","journal-title":"Stat Med"},{"issue":"10","key":"5359_CR30","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1210\/jc.2013-2193","volume":"98","author":"A Mahran","year":"2013","unstructured":"Mahran A et al (2013) The predictive value of circulating anti-Mullerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study. J Clin Endocrinol Metab 98(10):4170\u20134175","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"5359_CR31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3109\/09513590.2013.813466","volume":"29","author":"A El-Mazny","year":"2013","unstructured":"El-Mazny A, Abou-Salem N (2013) Anti-Mullerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome. Gynecol Endocrinol 29(9):826\u2013829","journal-title":"Gynecol Endocrinol"},{"issue":"10","key":"5359_CR32","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1093\/humrep\/dei164","volume":"20","author":"MJ Eijkemans","year":"2005","unstructured":"Eijkemans MJ et al (2005) Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2). Hum Reprod 20(10):2830\u20132837","journal-title":"Hum Reprod"},{"issue":"9","key":"5359_CR33","first-page":"95","volume":"7","author":"M Costello","year":"2019","unstructured":"Costello M et al (2019) A review of first line infertility treatments and supporting evidence in women with polycystic ovary syndrome. Med Sci (Basel) 7(9):95","journal-title":"Med Sci (Basel)"},{"issue":"1","key":"5359_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.fertnstert.2006.05.064","volume":"87","author":"KS Richter","year":"2007","unstructured":"Richter KS et al (2007) Relationship between endometrial thickness and embryo implantation, based on 1294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos. Fertil Steril 87(1):53\u201359","journal-title":"Fertil Steril"},{"issue":"4","key":"5359_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/humupd\/dmu011","volume":"20","author":"A Kasius","year":"2014","unstructured":"Kasius A et al (2014) Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update 20(4):530\u2013541","journal-title":"Hum Reprod Update"},{"issue":"5","key":"5359_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/humrep\/dex035","volume":"32","author":"NS Weiss","year":"2017","unstructured":"Weiss NS et al (2017) Endometrial thickness in women undergoing IUI with ovarian stimulation. How thick is too thin? A systematic review and meta-analysis. Hum Reprod 32(5):1009\u20131018","journal-title":"Hum Reprod"},{"issue":"6","key":"5359_CR37","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/0002-9378(86)90147-X","volume":"155","author":"S Aksel","year":"1986","unstructured":"Aksel S et al (1986) Effects of clomiphene citrate on cytosolic estradiol and progesterone receptor concentrations in secretory endometrium. Am J Obstet Gynecol 155(6):1219\u20131223","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"5359_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/eurpub\/cks033","volume":"23","author":"F Grossschadl","year":"2013","unstructured":"Grossschadl F, Stronegger WJ (2013) Long-term trends in obesity among Austrian adults and its relation with the social gradient: 1973\u20132007. Eur J Pub Health 23(2):306\u2013312","journal-title":"Eur J Pub Health"},{"issue":"6","key":"5359_CR39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/humupd\/dmw027","volume":"22","author":"D Dewailly","year":"2016","unstructured":"Dewailly D et al (2016) Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update 22(6):709\u2013724","journal-title":"Hum Reprod Update"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05359-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-019-05359-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05359-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:25:42Z","timestamp":1604535942000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-019-05359-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5359"],"URL":"https:\/\/doi.org\/10.1007\/s00404-019-05359-7","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"assertion":[{"value":"25 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We declared that we have no conflict of interest in relation to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The raw data files may be available upon request or as a supplementary file if the paper is accepted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"On April 25th 2017, the study was approved by the Institutional Review Board of the Medical University of Vienna (IRB number: 1307\/2017). Due to the retrospective design of the study, the informed consent to participate is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}}]}}